Featured Image of Top News Story: Dr. William Towner named 2022 SCPMG Physician Researcher of the Year

Dr. William Towner named 2022 SCPMG Physician Researcher of the Year

William J. Towner, MD, FACP, FIDSA, physician director of the Kaiser Permanente Southern California Clinical Trials Program, has been named the 2022 Southern California Permanente Medical Group Physician Researcher of the Year. The award has been given each year since 2007 to recognize a physician ...

  • Five questions for … Dr. Matthew Mefford

    December 16, 2021
    Matthew Mefford, PhD, is a cardiovascular disease epidemiologist and research scientist in the Kaiser Permanente Southern California Department of Research & Evaluation. His research interests include heart failure, cardiovascular disease disparities, risk factors and outcomes, and the intersection of chronic disease and infectious diseases. He also maintains a broad focus on applying epidemiologic methods to ...
    Read more...
  • Heart attack patients may have delayed care over COVID-19 concerns

    December 14, 2021
    A study of Kaiser Permanente Southern California members shows that rates of hospital admissions or emergency department visits for heart attacks dropped significantly after stay-at-home orders for the COVID-19 pandemic began in 2020. These findings, published in The Permanente Journal on December 13, 2021, suggest that people may have delayed seeking care out of concern ...
    Read more...
  • New Virtual Research Office enables physician research

    December 14, 2021
    Kaiser Permanente Southern California has launched a new Virtual Research Office portal to make it easier for physicians to conduct clinical research that can have a direct impact on the quality of care provided to Kaiser Permanente members. The new portal, developed and housed by the Department of Research & Evaluation, provides a single point of ...
    Read more...
  • People with HIV are at increased risk for heart failure

    December 13, 2021
    People with HIV are at higher risk of developing heart failure than people without HIV, a new study found. The research, published Dec. 13, 2021, in Mayo Clinic Proceedings, is one of the largest studies to investigate heart failure risk in people with HIV and how that risk varies by age, gender, race, and ethnicity. “Cardiovascular ...
    Read more...
  • Moderna COVID-19 vaccine is effective 5 months after 2nd dose

    November 29, 2021
    Kaiser Permanente research in Southern California published November 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the second dose. Effectiveness was 87% against COVID-19 infection, 96% against COVID-19 hospitalization, and 98% against COVID-19 death. “This research provides reassuring evidence of the high effectiveness of ...
    Read more...
  • Higher risk of dementia for older adults living with HIV

    November 28, 2021
    A study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The rate of dementia decreased over time for both groups but remained higher for those with HIV, reported research published in the journal AIDS. The study compared more than 13,000 people with HIV, ages ...
    Read more...
  • Exercise during pandemic linked to better mental health

    November 10, 2021
    People who exercised more during the initial lockdown period of the COVID-19 pandemic experienced less anxiety and depression than those who didn’t exercise, according to new research published November 11, 2021, in Preventive Medicine. The research also showed that people who spent more time outdoors typically experienced lower levels of anxiety and depression than those ...
    Read more...
  • Five questions for … Dr. Stanley Xu

    November 10, 2021
    Dr. Stanley Xu is a senior research scientist biostatistician in the Division of Biostatistics Research in the Department of Research & Evaluation. He has served as principal investigator, co-investigator, and lead biostatistician on randomized trials and observational studies funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Centers for Disease Control ...
    Read more...
  • Kaiser Permanente members invited to join flu vaccine study

    October 27, 2021
    The Centers for Disease Control and Prevention has selected Kaiser Permanente Southern California as a new site in its U.S. Flu Vaccine Effectiveness network. Kaiser Permanente Southern California is inviting its members to participate in a nationwide study of how well flu and COVID-19 vaccines are working. It is one of 2 new sites selected by ...
    Read more...
  • New study looking at millions of vaccinated and unvaccinated people found no increased risk of death among COVID-19 vaccine recipients

    October 22, 2021
    COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published Oct. 22, 2021 in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report. “Despite numerous studies showing the safety of COVID-19 vaccines, some people have remained hesitant to get vaccinated,” said lead author Stanley ...
    Read more...